Gene: RIBC2
Official Full Name: RIB43A domain with coiled-coils 2provided by HGNC
Gene Summary: Predicted to be involved in flagellated sperm motility. Located in axonemal microtubule. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04809 | RIBC2 Knockout cell line (HeLa) | Human | RIBC2 | 1:3~1:6 | Negative | Online Inquiry |
KO04810 | RIBC2 Knockout cell line (HCT 116) | Human | RIBC2 | 1:2~1:4 | Negative | Online Inquiry |
KO04811 | RIBC2 Knockout cell line (A549) | Human | RIBC2 | 1:3~1:4 | Negative | Online Inquiry |
RIBC2 Gene Knockout Cell Lines are advanced cellular models specifically engineered to facilitate the study of the RIBC2 gene, a critical component in various biological pathways. These cell lines have been meticulously created using CRISPR/Cas9 technology, resulting in the targeted disruption of the RIBC2 gene, which allows for comprehensive investigation into its functional roles and interactions within cellular systems. This knockout approach enables researchers to elucidate the gene's contribution to processes such as cellular signaling, metabolism, and potential implications in disease states.
The key functions of RIBC2 Gene Knockout Cell Lines lie in their ability to serve as valuable tools for gene function analysis, drug discovery, and therapeutic research. By lacking the functional expression of RIBC2, these cell lines present a unique opportunity to observe the resultant phenotypic changes and biochemical pathways that may be impacted. Mechanistically, utilizing these knockout lines can aid in the understanding of gene redundancy, compensatory mechanisms, and the gene’s role in pathophysiological contexts, thus enhancing our overall understanding of cellular biology.
Scientifically, the ability to study gene knockouts in a controlled environment has profound implications in research and clinical settings, particularly in the areas of cancer biology, regenerative medicine, and genetic disorders. These cell lines are indispensable for high-throughput screening and validating potential targets for drug development, providing insights that can lead to novel therapeutic strategies.
In comparison to alternative models, RIBC2 Gene Knockout Cell Lines offer significant advantages, including precise gene deletion without off-target effects commonly encountered with other gene-editing methods. Additionally, they are available in a wide variety of background cell types, which enables researchers to choose the most relevant cellular context for their specific applications.
For researchers and clinicians seeking to deepen their understanding of gene function or develop cutting-edge therapeutic solutions, RIBC2 Gene Knockout Cell Lines represent a powerful resource that can drive innovation and discovery. Our company prides itself on delivering high-quality, reliable biological products that empower the scientific community. With our expertise in genetic engineering and commitment to excellence, we are dedicated to enhancing research capabilities and advancing the field of molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.